Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cristina,d'Abramo

第一单位： The Litwin-Zucker Center for Alzheimer's Disease & Memory Disorders, Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY 11030, USA.

作者： Cristina,d'Abramo ^[1] ; Luciano,D'Adamio ^[2] ; Luca,Giliberto ^[1]

作者单位： The Litwin-Zucker Center for Alzheimer's Disease & Memory Disorders, Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY 11030, USA. ^[1] Rutgers Alzheimer's Disease & Dementia Research Center (RUADRC), Rutgers Brain Health Institute, Rutgers University, Piscataway, NJ 08854, USA. ^[2] Northwell Health Neuroscience Institute, Northwell Health System, Manhasset, NY 11030, USA. ^[3] Donald and Barbara Zucker School of Medicine, Hofstra University, Hempstead, NY 11549, USA. ^[4]

关键词 Alzheimer’s disease Multiplex NfL SiMoA amyloid biomarkers blood cerebrospinal fluid soluble TREM2 tau

DOI 10.3390/jpm10030116

PMID 32911755

发布时间 2021-09-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of personalized medicine

2020年10卷3期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use.

Journal of personalized medicine

相似文献

Journal of personalized medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use.

Journal of personalized medicine

相似文献

Journal of personalized medicine

相关期刊

检索历史清除